PMA device
Medtronic DBS Therapy for Epilepsy
Medtronic, Inc. · Stimulator, Thalamic, Epilepsy, Implanted (MBX, Class III) · First FDA decision Apr 27, 2018, newest Apr 27, 2018Epilepsy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
389
Naming "DBS Therapy"
MAUDE reports
0
Brand "DBS Therapy", since 2015
PubMed studies
418
Mentioning "DBS Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic DBS Therapy for Epilepsy
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MEDTRONIC DBS THERAPY FOR EPILEPSYPMA supplement
P960009-S219 · Decided Apr 27, 2018 · 1,158 days after receipt · Panel Track
Device type: Stimulator, thalamic, epilepsy, implanted (MBX) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "DBS Therapy", any status and sponsor, newest update first.
- Precision Closed-loop Brain-Computer Interface Neuromodulation for Treatment-Resistant DepressionNot yet recruiting
Shanghai Mental Health CenterAcademic, hospital or other
NCT07783906 · 70 participants (planned) · Start Dec 2026 · Primary completion Dec 31, 2028
Device: Closed-loop Deep Brain Stimulation (DBS); Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) · For: Treatment-Resistant Major Depressive Disorder; Major Depressive Disorder
- Vercise™ DBS Dystonia Prospective StudyRecruiting
Boston Scientific CorporationPublic (BSX)
NCT02686125 · 300 participants (planned) · Start Mar 7, 2016 · Primary completion Dec 2030
Device: Deep Brain Stimulation (DBS) · For: Dystonia
Sites: Ghent, Belgium; Leuven, Belgium; Halifax, Canada · 36 sites in all
- DBS for Obsessive-Compulsive DisorderRecruiting
Northwell HealthAcademic, hospital or other
NCT02773082 · 50 participants (planned) · Start Jul 6, 2024 · Primary completion Jan 1, 2030
Device: Reclaim™ DBS Therapy · For: Obsessive-Compulsive Disorder (OCD)
Sites: Queens, New York
386 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DBS Therapy", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MBX
439 reports: 232 malfunction, 205 injury, 2 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2240-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
- Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2241-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Z-0206-2025 · Started Sep 24, 2024 · Posted by FDA Oct 23, 2024
Reason given: A limited number of Percept RC Implantable Neurostimulators (INS), Model B35300 will not be able to communicate with the A610 DBS Clinician Programmer Application upon use and an "Invalid Device" message will appear.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
17 more recall records with a free account
Published research
The most relevant PubMed records for "DBS Therapy"[tiab]. The summary above synthesizes these.
- Childhood dystonias.
Tabbal SD · Curr Treat Options Neurol · 2015
- Deep brain stimulation for epilepsy.
Salanova V · Epilepsy Behav · 2018Review
- Lateral cerebellothalamic tract activation underlies DBS therapy for Essential Tremor.
Brinda A, Slopsema JP, Butler RD, et al. · Brain Stimul · 2023Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- Orientation selective deep brain stimulation.
Lehto LJ, Slopsema JP, Johnson MD, et al. · J Neural Eng · 2017Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Deep brain stimulation for dementias.
Xu DS, Ponce FA · Neurosurg Focus · 2018Review
- Self-injurious behavior in Tourette syndrome.
Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J · J Neurol · 2022
- Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder.
Provenza NR, Reddy S, Allam AK, et al. · Nat Med · 2024Clinical Study
- Stereotactic Radiofrequency Lesioning for Movement Disorders.
Taira T, Horisawa S, Takeda N, et al. · Prog Neurol Surg · 2018Review
- Computational Neurosurgery in Deep Brain Stimulation.
Germann J, Gouveia FV, Beyn ME, et al. · Adv Exp Med Biol · 2024Review
- Classification of electrically-evoked potentials in the parkinsonian subthalamic nucleus region.
Rosing J, Doyle A, Brinda A, et al. · Sci Rep · 2023Research Support, N.I.H., Extramural
- Deep brain stimulation for the treatment of tremor.
Chandra V, Hilliard JD, Foote KD · J Neurol Sci · 2022Review
- The adaptive deep brain stimulation challenge.
Arlotti M, Rosa M, Marceglia S, et al. · Parkinsonism Relat Disord · 2016Review, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MBX.
- Master Activa®, Percept and SenSight Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.